Toy Andrew
Chief Executive Officer
Toy Andrew has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Toy Andrew is listed as Chief Executive Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE. Inside the rolling window, Toy Andrew reported no open-market purchases and 3 open-market sales totaling $2.4M in CLOV. The largest disclosed transaction in the window is a sale of 313,476 CLOV shares on Jul 1, 2026, worth $1.7M.
Companies traded
Other insiders at CLOV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Toy Andrew made?
Toy Andrew has filed 12 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Toy Andrew trade?
Toy Andrew has filed SEC Form 4 disclosures for 1 company, including CLOV.
When was Toy Andrew's most recent SEC Form 4 filing?
Toy Andrew's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Toy Andrew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Toy Andrew is listed as Chief Executive Officer.
What is Toy Andrew's total buy and sell value in the current window?
Inside the rolling retention window, Toy Andrew bought $0 and sold $2.4M based on SEC Form 4 filings.
What was Toy Andrew's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 313,476 CLOV shares on 2026-07-01, worth $1.7M, per SEC Form 4 filings.